RD118 / IASO BIO 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RD118 / IASO BIO
CAR-GPRC5DCI001, NCT05219721: A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Recruiting
1
18
RoW
CAR-T (CAR-GPRC5D)
Chunrui Li, Nanjing IASO Biotechnology Co., Ltd
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia
12/22
03/24
RD138CI002, NCT05759793: A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Recruiting
1
12
RoW
CAR-T (CAR-GPRC5D)
Nanjing IASO Biotechnology Co., Ltd., Ruijin Hospital
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia
03/24
03/25

Download Options